Prague Med. Rep. 2026, 127, 197-210

https://doi.org/10.14712/23362936.2026.26

Vaccine Prophylaxis of Viral Hepatitis B among the Adult Population in the City of Jalal-Abad (Kyrgyz Republic)

Saparbai Zholdoshev1ID, Nemat Temirov2ID, Myskal Abdikerimova3ID, Sabira Salieva4ID, Begimai Abdimomunova1ID

1Faculty of Medicine, Osh State University, Osh, Kyrgyz Republic
2Department of Health Organization, Jalal-Abad State University, Jalal-Abad, Kyrgyz Republic
3Department of Medicine, Kyrgyz-Russian Slavic University, Bishkek, Kyrgyz Republic
4Department of Therapy, Osh State University, Osh, Kyrgyz Republic

Received July 21, 2025
Accepted September 8, 2026

References

1. Akmatov, M., Beisheeva, N., Nurmatov, A., Gulsunai, S., Saikal, K., Derkenbaeva, A., Abdrahmanova, Z., Prokein, J., Klopp, N., Illig, T., Kasymov, O., Nurmatov, Z., Pessler, F. (2023) The changing epidemiology of viral hepatitis in a post-Soviet country – The case of Kyrgyzstan. Pathogens 12(8), 989. <https://doi.org/10.3390/pathogens12080989>
2. Al-Busafi, S., Alwassief, A. (2024) Global perspectives on the hepatitis B vaccination: Challenges, achievements, and the road to elimination by 2030. Vaccines 12(3), 288. <https://doi.org/10.3390/vaccines12030288>
3. Berezenko, V. S., Tkalik, O. M., Dyba, M. B., Krat, V. V., Mykhailiuk, H. Z. (2021) Assessment of liver fibrosis in children with chronic HBV infection by non-invasive methods. Modern Pediatrics Ukraine 6, 19–24. <https://doi.org/10.15574/SP.2021.118.19>
4. Berezenko, V. S., Mykhailiuk, K. Z., Krechko, Y. V., Tkalyk, O. M., Dyba, M. B., Bezpala, A. V. (2022) Ornithine transcarbamylase deficiency is a little-known rare disease in pediatric hepatology (clinical case). Modern Pediatrics Ukraine 7, 111–116. <https://doi.org/10.15574/SP.2022.127.111>
5. Bixler, D., Roberts, H., Panagiotakopoulos, L., Nelson, N., Spradling, P., Teshale, E. (2023) Progress and unfinished business: Hepatitis B in the United States, 1980–2019. Public Health Rep. (Epub ahead of print)
6. Bogoyavlenskiy, A., Alexyuk, M., Alexyuk, P., Berezin, V., Almalki, F. A., Ben Hadda, T., Alqahtani, A. M., Ahmed, S. A., Dall’Acqua, S., Jamalis, J. (2023a) Computer analysis of the inhibition of ACE2 by flavonoids and identification of their potential antiviral pharmacophore site. Molecules 28(9), 3766. <https://doi.org/10.3390/molecules28093766>
7. Bogoyavlenskiy, A., Zaitseva, I., Alexyuk, P., Alexyuk, M., Omirtaeva, E., Manakbayeva, A., Moldakhanov, Y., Anarkulova, E., Imangazy, A., Berezin, V., Korulkin, D., Hasan, A. H., Noamaan, M., Jamalis, J. (2023b) Naturally occurring isorhamnetin glycosides as potential agents against influenza viruses: Antiviral and molecular docking studies. ACS Omega 8(50), 48499–48514. <https://doi.org/10.1021/acsomega.3c08407>
8. Bridges, C., Watson, T., Nelson, N., Chavez-Torres, M., Fineis, P., Ntiri-Reid, B., Wake, E., Leahy, J., Kurian, A., Hall, M., Kennedy, E. (2019) Challenges with hepatitis B vaccination of high-risk adults: A pilot program. Vaccine 37(35), 5111–5120. <https://doi.org/10.1016/j.vaccine.2019.05.089>
9. Chen, C. J. (2018) Global elimination of viral hepatitis and hepatocellular carcinoma: Opportunities and challenges. Gut 67(4), 595–598. <https://doi.org/10.1136/gutjnl-2017-315407>
10. Coffin, C., Ramji, A., Cooper, C., Miles, D., Doucette, K., Wong, P., Tam, E., Wong, D., Wong, A., Ukabam, S., Bailey, R., Tsoi, K., Conway, B., Barrett, L., Michalak, T., Congly, S., Minuk, G., Kaita, K., Kelly, E., Ko, H., Janssen, H., Uhanova, J., Lethebe, B., Haylock-Jacobs, S. M., Osiowy, C., Fung, S. (2019) Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: A descriptive study by the Canadian HBV Network. CMAJ Open 7(4), E610–E617. <https://doi.org/10.9778/cmajo.20190103>
11. Davlidova, S., Haley-Johnson, Z., Nyhan, K., Farooq, A., Vermund, S., Ali, S. (2020) Prevalence of HIV, HCV, and HBV in Central Asia and the Caucasus: A systematic review. Int. J. Infect. Dis. 104, 510–525. <https://doi.org/10.1016/j.ijid.2020.12.068>
12. Delam, H., Eidi, A., Keshtkaran, Z., Shahedi, A., Soufi, O., Rezaei, B., Bazrafshan, M. (2023) Changing the epidemiology and pattern of hepatitis B and C in the south of Fars province, Southern Iran: 2015–2021. Jundishapur J. Chronic Dis. Care 12(3), e137658. <https://doi.org/10.5812/jjcdc-137658>
13. Fanning, G., Zoulim, F., Hou, J., Bertoletti, A. (2019) Therapeutic strategies for hepatitis B virus infection: Towards a cure. Nat. Rev. Drug Discov. 18, 827–844. <https://doi.org/10.1038/s41573-019-0037-0>
14. Freeland, C., Kanu, F., Mohammed, Y., Nwokoro, U., Sandhu, H., Ikwe, H., Uba, B., Asekun, A., Akataobi, C., Adewole, A., Fadahunsi, R., Wisdom, M., Akudo, O., Ugbenyo, G., Simple, E., Waziri, N., Vasumu, J., Bahuli, A., Bashir, S., Isa, A., Ugwu, G., Obi, E., Binta, H., Bassey, B., Shuaib, F., Bolu, O., Tohme, R. (2023) Barriers and facilitators to hepatitis B birth dose vaccination: Perspectives from healthcare providers and pregnant women accessing antenatal care in Nigeria. PLOS Glob. Public Health 3(6), e0001332. <https://doi.org/10.1371/journal.pgph.0001332>
15. Iannacone, M., Guidotti, L. (2021) Immunobiology and pathogenesis of hepatitis B virus infection. Nat. Rev. Immunol. 22, 19–32. <https://doi.org/10.1038/s41577-021-00549-4>
16. Jaffe, A. E., Graupensperger, A., Blayney, J. A., Duckworth, J. C., Stappenbeck, C. A. (2022) The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies. Vaccine 40(12), 1888–1895. <https://doi.org/10.1016/j.vaccine.2022.01.038>
17. Julien, A., De Sousa Neto, A., Carvalho, A., Freitas, D., Moura, L., Moura, M., Da Silva Bezerra, S., De Lima Brito Magalhães, R. (2024) Analysis of scientific publications related to hepatitis B prevention in the last decade: 2013–2023. Rev. Prev. Infec. Saude 10, 5494.
18. Khetsuriani, N., Mosina, L., Van Damme, P., Mozalevskis, A., Datta, S., Tohme, R. A. (2021) Progress toward hepatitis B control – World Health Organization European Region, 2016–2019. MMWR Morb. Mortal. Wkly. Rep. 70(30), 1029–1035. <https://doi.org/10.15585/mmwr.mm7030a1>
19. Kucherenko, A. M., Moroz, L. V., Bevz, T. I., Bulavenko, V. I., Antypkin, Y. G., Berezenko, V. S., Dyba, M. B., Pampukha, V. M., Gorodna, O. V., Livshits, L. A. (2019) Investigation of rs11536889 + 3725G/C polymorphism of the TLR4 gene in patients with autoimmune and chronic viral hepatitis C. Cytol. Genet. 53(4), 300–306. <https://doi.org/10.3103/S0095452719040078>
20. Liang, Y., Bai, X., Liu, X., Zhang, Z., Pang, X., Nie, L., Qiu, W., Zhao, W., Hu, G. (2021) Hepatitis B vaccination coverage rates and associated factors: A community-based, cross-sectional study conducted in Beijing, 2019–2020. Vaccines 9(10), 1070. <https://doi.org/10.3390/vaccines9101070>
21. Liu, J., Liang, W., Jing, W., Liu, M. (2019) Countdown to 2030: Eliminating hepatitis B disease, China. Bull. World Health Organ. 97, 230–238. <https://doi.org/10.2471/BLT.18.219469>
22. Lu, P., Hung, M., Srivastav, A., Williams, W., Harris, A. (2021) Hepatitis B vaccination among adults with diabetes mellitus, U.S., 2018. Am. J. Prev. Med. 61(5), 652–664. <https://doi.org/10.1016/j.amepre.2021.04.029>
23. Mamontov, I., Tamm, T., Ivakhno, I., Panasenko, V., Padalko, V., Nepomniashchyi, V., Yaroshenko, A. (2023a) Histological liver changes in experimental obstructive cholestasis with partial outflow restoration. Gac. Med. Caracas 131(4), 875–885.
24. Mamontov, I. M., Tamm, T. I., Kramarenko, K. O., Ryabushchenko, D. D., Sytnik, D. A., Nepomniashchyi, V. V., Bardiuk, O. Y. (2023b) Endoscopic retrograde cholangiopancreatography and endoscopic decompression in the malignant obstruction of the extrahepatic biliary tracts – A retrospective analysis. Ukr. J. Radiol. Oncol. 31(1), 28–37.
25. Medical and Diagnostic Center of the Central Medical and Economic Institute (2023) Instruction “Laboratory Diagnostics of Hemocontact Viral Hepatitis (HBV, HCV, HBVD) in the Kyrgyz Republic”. Available at: https://www.cmei.com.ua/ru/articles/laboratornaya-diagnostika-virusnyh-gepatitov-2/
26. Nikolaev, E., Nikolov, N., Kostov, D., Vladov, N., Takorov, I., Mutafchiiski, V., Valcheva, M., Mircheva, I. (2021) Pringle maneuver and blood loss in the surgical treatment of liver hemangioma (LH). Surgical Chronicles 26(2), 191–195.
27. Nikolaev, E., Kostov, D., Valcheva, M., Mircheva, I. (2022) Spontaneous rupture of hepatic hemangioma – Three clinical cases and literature review. Surgical Chronicles 27(2), 261–265.
28. Nikolaev, E., Valcheva, M., Terzi, V., Kostov, D., Mircheva, I. (2025) Is the size of the liver hemangioma affected by the age and gender of the patients? Surgical Chronicles 30(1), 20–25.
29. Nurmanova, B. (2024) Reporting of progress toward eliminating viral hepatitis B and C in the Central Asian region. Adv. Gut Microbiome Res. 2024, 4818435. <https://doi.org/10.1155/2024/4818435>
30. Regional Center of Family Medicine (2025) Regional Center of Family Medicine. Available at: https://company.medelement.com/областной-центр-семейной-медицины-джалал-абад
31. Rudyk, D. V., Tutchenko, M. I., Chub, S. L., Besedinskyi, M. S. (2024) Three cases of fatal postoperative thromboembolic complications in patients with liver cirrhosis and bleeding from esophageal varicose veins after COVID-19. Wiad. Lek. 77(8), 1627–1632. <https://doi.org/10.36740/WLek202408114>
32. Sanai, F., Alghamdi, M., Dugan, E., Alalwan, A., Al-Hamoudi, W., Abaalkhail, F., Almasri, N., Razavi-Shearer, D., Razavi, H., Schmelzer, J., Alfaleh, F. (2020) A tool to measure the economic impact of hepatitis B elimination: A case study in Saudi Arabia. J. Infect. Public Health 13(11), 1715–1723. <https://doi.org/10.1016/j.jiph.2020.09.004>
33. Shulgau, Z., Sergazy, S., Krivoruchko, T., Sagindykova, B., Gulyayev, A. (2017) Study of hepatoprotective properties of RNA-containing drug “RN-13” on the model of acute tetrahllormethane induced hepatitis in rats. Georgian Med. News 265, 104–109. (in Russian)
34. Stasi, C., Silvestri, C., Voller, F. (2020) Hepatitis B vaccination and immunotherapies: An update. Clin. Exp. Vaccine Res. 9(1), 1–7. <https://doi.org/10.7774/cevr.2020.9.1.1>
35. Suleiman, M., Almalki, F. A., Ben Hadda, T., Kawsar, S. M. A., Chander, S., Murugesan, S., Bhat, A. R., Bogoyavlenskiy, A., Jamalis, J. (2023) Recent progress in synthesis, POM analyses and SAR of coumarin-hybrids as potential anti-HIV agents – A mini review. Pharmaceuticals (Basel) 16(11), 1538. <https://doi.org/10.3390/ph16111538>
36. Tarasyuk, B. A., Mostovenko, R. V., Berezenko, V. S., Dyba, M. B. (2013) An effect of iron metabolism on the pronouncedness of ultrasound markers of hepatic fibrosis in children with chronic hepatitis C. Vopr. Prakt. Pediatr. 8(1), 14–19.
37. Thomas, D. L. (2019) Global elimination of chronic hepatitis. N. Engl. J. Med. 380, 2041–2050. <https://doi.org/10.1056/NEJMra1810477>
38. Trevisan, A., Giuliani, A., Scapellato, M., Anticoli, S., Carsetti, R., Zaffina, S., Brugaletta, R., Vonesch, N., Tomao, P., Ruggieri, A. (2020) Sex disparity in response to hepatitis B vaccine related to the age of vaccination. Int. J. Environ. Res. Public Health 17(1), 327. <https://doi.org/10.3390/ijerph17010327>
39. Turmagambetova, A. S., Alexyuk, P. G., Bogoyavlenskiy, A. P., Zaitseva, I. A., Omirtaeva, E. S., Alexyuk, M. S., Sokolova, N. S., Berezin, V. E. (2017) Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine. Arch. Virol. 162(12), 3817–3826. <https://doi.org/10.1007/s00705-017-3560-5>
40. Tutchenko, M., Rudyk, D., Aslanian, S., Chub, S., Besedinskyi, M. (2024a) Recurrent variceal bleeding in alcoholic liver cirrhosis (a case report). Gastroenterology 58(3), 222–225. <https://doi.org/10.22141/2308-2097.58.3.2024.627>
41. Tutchenko, M. I., Rudyk, D. V., Besedinskyi, M. S. (2024b) Decompensated portal hypertension complicated by bleeding. Emergency Medicine 20(1), 13–18. <https://doi.org/10.22141/2224-0586.20.1.2024.1653>
42. Varghese, S., Sheeja, A., Johnson, A., Sushan, A., Nandini, C., Chandy, G., Rakesh, P., Joseph, M., David, A., Mathew, G., Alexander, P. (2021) Together let us confront it: An outbreak investigation of hepatitis B in Pathanamthitta district, Kerala. J. Family Med. Prim. Care 10(6), 2159–2165. <https://doi.org/10.4103/jfmpc.jfmpc_2343_20>
43. Villa, D. D. F., Navas, M. (2023) Vertical transmission of hepatitis B virus – An update. Microorganisms 11(5), 1140. <https://doi.org/10.3390/microorganisms11051140>
44. Wallace, J., Richmond, J., Howell, J., Hajarizadeh, B., Power, J., Treloar, C., Revill, P., Cowie, B., Wang, S., Stoové, M., Pedrana, A., Hellard, M. (2022) Exploring the public health and social implications of future curative hepatitis B interventions. Viruses 14(11), 2542. <https://doi.org/10.3390/v14112542>
45. Wang, S., Yeh, S., Chen, P. (2021) Unique features of hepatitis B virus-related hepatocellular carcinoma in pathogenesis and clinical significance. Cancers 13(10), 2454. <https://doi.org/10.3390/cancers13102454>
46. Woodring, J., Pastore, R., Brink, A., Ishikawa, N., Takashima, Y., Tohme, R. A. (2019) Progress toward hepatitis B control and elimination of mother-to-child transmission of hepatitis B virus – Western Pacific Region, 2005–2017. MMWR Morb. Mortal. Wkly. Rep. 68(8), 195–200. <https://doi.org/10.15585/mmwr.mm6808a2>
47. World Health Organization (2025) Hepatitis B. Available at: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
48. World Medical Association (2013) Declaration of Helsinki: Ethical principles for medical research involving human subjects. Available at: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
49. Yao, T., Li, Y., Zhang, Y., Sun, Y., Guo, Y., Wang, J., Song, X., Zhang, W., Wei, B., Bai, J., Wang, H., Yu, W., Wang, H., Jiao, L., Diao, Y., Liu, L., Shi, S., Yang, J., Ren, X., Liu, W., Fang, J., Wang, S., Liang, X., Feng, Y. (2024) Immunogenicity, safety, and persistence induced by triple and standard-strength four-dose hepatitis B vaccination regimens in hemodialysis patients: A multicenter, randomized, parallel-controlled trial in six cities in Shanxi Province. J. Inf. Diseases 231(4), 1049–1059. <https://doi.org/10.1093/infdis/jiae494>
50. Yendewa, G., James, P., Mohareb, A., Barrie, U., Massaquoi, S., Yendewa, S., Ghazzawi, M., Bockarie, T., Cummings, P., Diallo, I., Johnson, A., Vohnm, B., Babawo, L., Deen, G., Kabba, M., Sahr, F., Lakoh, S., Salata, R. (2023) Childhood hepatitis B immunization coverage and barriers in Sierra Leone, Liberia, and Guinea: Analysis of national surveys (2018–2020). Epidemiol. Infect. 151, e193. <https://doi.org/10.1017/S0950268823001735>
51. Zhang, C., Liu, Y., Zhao, H., Wang, G. (2022) Global patterns and trends in total burden of hepatitis B from 1990 to 2019 and predictions to 2030. Clin. Epidemiol. 2022(14), 1519–1533.
52. Zhao, H., Zhou, X., Zhou, Y. (2020) Hepatitis B vaccine development and implementation. Hum. Vaccin. Immunother. 16(7), 1533–1544. <https://doi.org/10.1080/21645515.2020.1732166>
53. Zheng, X., Li, X., Liu, J., Shi, L., Wang, H., Tian, K., Pan, X. (2022) Horizontal transmission might be a common route of hepatitis B virus exposure in highly endemic areas. J. Med. Virol. 94(10), 4983–4992. <https://doi.org/10.1002/jmv.27905>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive